Contemporary management of tricuspid regurgitation: An updated clinical review

Joshua T. Taylor, Geoffrey Chidsey, Thomas G. Disalvo, John G. Byrne, Simon Maltais

Research output: Contribution to journalReview articlepeer-review

5 Scopus citations


Tricuspid regurgitation (TR) is a complex and insidious valvular pathology that represents a complex decision and management algorithm for patients. TR is present in a significant proportion of the population and is especially prevalent in patients with advanced heart failure. Patients with TR have been demonstrated to have a decreased survival even with normal left heart function. TR can be a result of pathology that directly affects the valvular structure (ie, Ebstein anomaly) or as a result of increased forward pressures (ie, pulmonary hypertension, left heart failure). Conservative management of patients with TR is primarily symptomatic relief. Definitive therapy involves surgical repair of the tricuspid valve. Furthermore, as more patients develop advanced heart failure, the management of TR in patients with left ventricular assist devices has become necessary because of the evidence of increased in-hospital morbidity and a trend toward decreased survival.

Original languageEnglish (US)
Pages (from-to)174-183
Number of pages10
JournalCardiology in Review
Issue number4
StatePublished - Jul 2013


  • management
  • tricuspid regurgitation

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine


Dive into the research topics of 'Contemporary management of tricuspid regurgitation: An updated clinical review'. Together they form a unique fingerprint.

Cite this